Skip to main content
. 2023 Oct 26;13(11):2118. doi: 10.3390/life13112118

Figure 2.

Figure 2

Changes in FVC and DLco for each group over a 12-month period. (A) Changes in FVC % predicted over 12 months for each pirfenidone group. (B) Changes in DLco % predicted over 12 months for each pirfenidone group. FVC, forced vital capacity; DLco, diffusing capacity of the lung for carbon monoxide.